SEARCH

Current Location: DOTmed News > Industry Headlines > This Story

(1)
Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

More Industry Headlines

Philips suspends CT and PET/CT production at Ohio facility Setback for customers and the company.

Varian's seven year patent dispute comes to an end Company will pay about $35 million.

FDA OKs GE's new CT scanner Ideal for challenging cases.

MRI technique can help treat concussion patients Measures white brain matter damage.

Special report: Contrast media One size does not fit all.

What's the big-picture impact of HIT on health care? Q&A with thought leader Bipin Thomas.

ABT's compact biomarker generator comes to Russia Ideal for the growing Russian market.

ClearMRI gets FDA clearance for MRI adaptor New option to extend the life of MRI systems.

Sebelius steps down from HHS post Sylvia Mathews Burwell to succeed Sebelius.

Physician payment data now available CMS releases records and AMA pushes back.

Deal valued at $5.7 million.

Accuray to buy radiation therapy software company for $5.7 million

by Brendon Nafziger , DOTmed News Associate Editor
Accuray Inc. said Monday that it would buy Morphormics Inc., a company that designs software for planning prostate radiation treatments, for approximately $5.7 million.

Accuray said it has been licensing Morphormics' technology since 2008, shortly before the product was first released commercially in 2009 as part of an Accuray treatment planning system.

Story Continues Below Advertisement

Free Whitepaper: Are you giving up millions in costs & lost revenue?

Free White Paper Download: Five Costs You Don't Typically Associate with Clinical Engineering. Enhance your understanding. Download the complete white paper for free today.



Morphormics' autocontouring software uses mathematical models to create individual 3-D atlases of patients' organs based on CT and other medical images. Its first product, MxStruct/Pelvis, can identify and mark the boundaries of the prostate so radiation oncologists can better target the organ while sparing surrounding healthy tissue.

The company was spun off from University of North Carolina at Chapel Hill in 2001 by professors Edward Chaney, Stephen Pizer and Sarang Joshi.

With the deal, Accuray said it would extend autocontouring abilities for its CyberKnife and TomoTherapy systems. Sunnyvale, Calif.-based Accuray acquired TomoTherapy last year.

Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2014 DOTmed.com, Inc.
ALL RIGHTS RESERVED